USE OF ANABOLIC STEROID, STANOZOLOL, TO PROMOTE WEIGHT GAIN IN UNDERWEIGHT PATIENTS.
ROSNICK
M J
MJ
D000293:Adolescent; D000437:Alcoholism; D045930:Anabolic Agents; D000787:Angina Pectoris; D001007:Anxiety; D001249:Asthma; D001835:Body Weight; D002100:Cachexia; D002908:Chronic Disease; D004358:Drug Therapy; D005853:Geriatrics; D006801:Humans; D006973:Hypertension; D010003:Osteoarthritis; D020734:Parkinsonian Disorders; D013197:Stanozolol; D013256:Steroids; D045165:Testosterone Congeners; D013851:Thinness; D014116:Toxicology; D015430:Weight Gain
D045930:Anabolic Agents; D013256:Steroids; D045165:Testosterone Congeners; D013197:Stanozolol
ADOLESCENCE; ALCOHOLISM; ANABOLIC STEROIDS; ANGINA PECTORIS; ANXIETY; ASTHMA; BODY WEIGHT; CACHEXIA; CHRONIC DISEASE; DRUG THERAPY; GERIATRICS; HYPERTENSION; OSTEOARTHRITIS; PARKINSONISM; STANOZOLOL; TOXICOLOGIC REPORT